Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Micha

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Obstetrics and Gynecology|February 1, 1987
Prophylactic mezlocillin in radical hysterectomyJ P Micha, P R Kucera, J P Birkett, et al.
American Journal of Obstetrics and Gynecology|August 1, 1985
Malignant ovarian germ cell tumors: a review of thirty-six casesJ P Micha, P R Kucera, M L Berman, et al.
Obstetrics and Gynecology|October 1, 1985
Semipermanent right atrial catheter in gynecologic cancer patientsM A Rettenmaier, J P Micha, P S Braly, et al.
European Journal of Gynaecological Oncology|November 17, 2010
Bevacizumab, paclitaxel and carboplatin for advanced ovarian cancer: low risk of gastrointestinal and cardiovascular toxicityL N Abaid, K L Lopez, J P Micha, et al.
Gynecologic Oncology|July 1, 1985
Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assayJ P Micha, P R Kucera, C U Preve, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|September 17, 2009
A heavily pigmented vaginal perivascular epithelioid cell neoplasmM A Rettenmaier, N Zekry, M Chang, et al.
British Journal of Cancer|November 4, 2010
The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional reviewN B Rettenmaier, C R Rettenmaier, T Wojciechowski, et al.
Gynecologic Oncology|November 1, 1984
The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experienceJ A Stratton, P R Kucera, J P Micha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2013
Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian carcinomaJ P Micha, J V Brown, M A Rettenmaier, et al.
Gynecologic Oncology|March 1, 1990
Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancerP R Kucera, M L Berman, P Treadwell, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Obstetrics and Gynecology|February 1, 1987
Prophylactic mezlocillin in radical hysterectomyJ P Micha, P R Kucera, J P Birkett, et al.
American Journal of Obstetrics and Gynecology|August 1, 1985
Malignant ovarian germ cell tumors: a review of thirty-six casesJ P Micha, P R Kucera, M L Berman, et al.
Obstetrics and Gynecology|October 1, 1985
Semipermanent right atrial catheter in gynecologic cancer patientsM A Rettenmaier, J P Micha, P S Braly, et al.
European Journal of Gynaecological Oncology|November 17, 2010
Bevacizumab, paclitaxel and carboplatin for advanced ovarian cancer: low risk of gastrointestinal and cardiovascular toxicityL N Abaid, K L Lopez, J P Micha, et al.
Gynecologic Oncology|July 1, 1985
Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assayJ P Micha, P R Kucera, C U Preve, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|September 17, 2009
A heavily pigmented vaginal perivascular epithelioid cell neoplasmM A Rettenmaier, N Zekry, M Chang, et al.
British Journal of Cancer|November 4, 2010
The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional reviewN B Rettenmaier, C R Rettenmaier, T Wojciechowski, et al.
Gynecologic Oncology|November 1, 1984
The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experienceJ A Stratton, P R Kucera, J P Micha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2013
Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian carcinomaJ P Micha, J V Brown, M A Rettenmaier, et al.
Gynecologic Oncology|March 1, 1990
Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancerP R Kucera, M L Berman, P Treadwell, et al.
Pageof 4